全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Randomized trial of the effect of intravenous paracetamol on inflammatory biomarkers and outcome in febrile critically ill adults

DOI: 10.1186/2008-2231-20-12

Keywords: Fever, Systemic Inflammatory Response Syndrome (SIRS), Intensive Care Unit (ICU), Paracetamol, Cytokines

Full-Text   Cite this paper   Add to My Lib

Abstract:

In a prospective, randomized controlled study, critically ill patients with fever (T?≥?38.3°C), SIRS diagnosed within 24 hours of Intensive Care Unit (ICU) admission and Acute Physiology and Chronic Health Evaluation II (APACHE II) score ≥10 were randomized into two groups. Upon appearance of fever, one group received intravenous paracetamol 650?mg every 6 hours for 10?days and other group received no treatment unless temperature reached 40°C. Body temperature, Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sepsis-related Organ Failure Assessment (SOFA) scores, length of ICU stay, ICU mortality and infectious complications were recorded. Levels of Interleukin-1 alpha (IL-1α), IL-6, IL-10, Tumour Necrosis Factor alpha (TNFα) and High-Sensitive C-Reactive Protein (HS-CRP) were assessed at baseline and 2, 6 and 24 hours after intervention.During a period of 15-month screening, 20 patients met the criteria and randomized to the control or paracetamol group. Body temperature decreased significantly in the paracetamol group (p?=?0.004) and control group (p?=?0.001) after 24 hours, but there was no significant difference between two groups at this time point (p?=?0.649). Levels of IL-6 and IL-10 decreased significantly (p?=?0.025 and p?=?0.047, respectively) in the paracetamol group at 24 hours but this was not of statistical significance in control group. No patterns over time in each group or differences across two groups were found for HS-CRP, TNFα, and IL-1α (p?>?0.05). There were no differences regarding ICU length of stay, mortality and infectious complications between both groups.These results suggest that antipyretic therapy may not be indicated in all ICU patients. Allowing fever to take its natural course does not appear to have detrimental effects on critically ill patients with SIRS and may avoid unnecessary expenses.Fever, defined as an increase in body temperature above 38.3°C (100.4°F), is among the most frequently detected abnormal physic

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133